Alpha Dna Investment Management LLC Halozyme Therapeutics, Inc. Transaction History
Alpha Dna Investment Management LLC
- $250 Million
- Q2 2024
A detailed history of Alpha Dna Investment Management LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 8,476 shares of HALO stock, worth $484,911. This represents 0.18% of its overall portfolio holdings.
Number of Shares
8,476
Previous 6,676
26.96%
Holding current value
$484,911
Previous $271,000
63.47%
% of portfolio
0.18%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding HALO
# of Institutions
488Shares Held
122MCall Options Held
208KPut Options Held
66.3K-
Black Rock Inc. New York, NY17.6MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$737 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$333 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$231 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$213 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.97B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...